Alnylam

Articles

Patient focus December 7, 2020 Alnylam Releases 2nd Annual Patient Access Philosophy Report The 2020 Alnylam Patient Access Philosophy Report details Alnylam's progress against key metrics related to patient access to its innovative RNAi therapeutics. Read More ›
Top Places 2020 November 20, 2020 6 in a Row! Alnylam Named a Boston Globe Top Place to Work for 2020 Alnylam has been named to The Boston Globe's Top Places to Work list for 2020, marking 6th years in a row. Read More ›
Careers culture October 29, 2020 Alnylam Named a Science Magazine Top Employer for 2nd Year in a Row Alnylam has been named to Science Magazine and Science Career's Top Employers list for the second year in a row. Read More ›
EU Biotech Pact October 1, 2020 A New European Biotech Social Pact The European Pact builds on Alnylam’s own pledge, encouraging biotech companies to be a force for good in partnering with European authorities, citizens and... Read More ›
Patient focus September 14, 2020 Navigating AHP and Pain During a Pandemic As the COVID-19 pandemic continues to have a significant impact on people and communities around the world, it poses unique challenges for people living with... Read More ›
Perspectives September 2, 2020 With Innovation in Market Access, European Patients Can Fully Experience Biotech’s Transfo ... What’s needed is a larger measure of creativity, flexibility and coordination around market access. This must become the new baseline environment in which... Read More ›
Leadership August 6, 2020 Alnylam Promotes Dr. Yvonne Greenstreet to President & COO Dr. Yvonne Greenstreet, has been elevated to the role of President of Alnylam. She will retain her COO role as well. Read More ›
KHI Article August 3, 2020 How to Evaluate a Medicine for the Treatment of an Ultra-rare Disease Such as PH1 For a new medicine to become available, it needs to undergo stringent testing in clinical trials to evaluate its safety and, importantly, its efficacy... Read More ›
Alnylam Pride 2020 Group Photo Feature June 24, 2020 Celebrating a Pride Month Unlike Any Other We asked members of our SAGA (Sexuality and Gender Alliance) employee resource network (ERN) how they've been celebrating Pride this year, given the... Read More ›
Leadership June 9, 2020 John Maraganore in "Biotechnology in the Time of COVID-19: Commentaries from the Front Lin ... In a new e-book, dozens of biopharma industry leaders, including our CEO John Maraganore, share their perspectives from the industry's unique vantage point... Read More ›
Subscribe to Articles